3 Undervalued Pharmaceuticals Stocks for Wednesday, July 15
Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, July 15 based on AAII’s Stock Grades.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Michael Rose
Tudor Pop
| Share Statistics | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $455.0 | $646.7 | 35% |
|
| Shares Out (Mil) | 73.0 | 44.2 | 56% |
|
| Institutional Ownership | 34.4% | 85.5% | 14% |
|
| Float (Mil) | 65.7 | 47.3 | 53% |
|
| Beta | 1.42 | 0.69 | 81% |
|
| Avg Daily Volume (000s) | 99 | 391 | 34% |
|
| Price Change (52-week) |
(19.4%) | 69.0% | 29% |
|
| Growth | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 29.2% | 6.7% | 89% |
|
| Net Income (5yr) | (54.2%) | (1.6%) | 6% |
|
| EPS (5yr) | (48.0%) | 14.9% | 4 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.8%) | (14.9%) | 36% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | na | na | |
| Current EPS | ($0.220) | na | na | |
| Month Ago EPS | ($0.250) | na | na | |
| # Rev Up | 0 | na | na | |
| # Rev Down | 1 | na | na | |
| Three Months Ago EPS | ($0.250) | na | na | |
| Year/Year Chg | 19.6% | na | na | |
| Financials | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $836 | $291 | 48% |
|
| Net Income (TTM) (Mil) | ($259) | ($11) | 5% |
|
| EPS (TTM) | ($3.581) | ($0.700) | 10% |
|
| Operating Cash Flow (TTM) (Mil) | $89 | ($6) | 51% |
|
| Net Cash Flow (TTM) (Mil) | $17 | $5 | 61% |
|
| Long-Term Debt (Q1) (Mil) | $471 | $6 | 58% |
|
| Enterprise Value (Q1) (Mil) | $846 | $463 | 39% |
|
| Valuation | VRNO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.67 | 2.81 | 11% |
|
| P/E | na | 17.7 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 47.8% | 69.1% | 59% |
|
| Net Margin | (30.9%) | (2.3%) | 14% |
|
| ROA | (14.2%) | (23.4%) | 23% |
|
| ROE | (32.2%) | (20.6%) | 19% |
|
| Liabilities to Assets | 60.3% | 32.0% | 54% |
|
| F-Score | 6 | 3 | 67% |
|
Verano Holdings Corp. did not pass any screens on 8/21/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors